2880 related articles for article (PubMed ID: 7758088)
41. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
Ohashi A; Funasaka Y; Ueda M; Ichihashi M
Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
[TBL] [Abstract][Full Text] [Related]
42. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts.
Degen WG; Weterman MA; van Groningen JJ; Cornelissen IM; Lemmers JP; Agterbos MA; Geurts van Kessel A; Swart GW; Bloemers HP
Int J Cancer; 1996 Feb; 65(4):460-5. PubMed ID: 8621228
[TBL] [Abstract][Full Text] [Related]
43. Labial melanotic macule: a clinical, histopathologic, and ultrastructural study.
Ho KK; Dervan P; O'Loughlin S; Powell FC
J Am Acad Dermatol; 1993 Jan; 28(1):33-9. PubMed ID: 8425968
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.
Naramura M; Gillies SD; Mendelsohn J; Reisfeld RA; Mueller BM
Cancer Immunol Immunother; 1993 Oct; 37(5):343-9. PubMed ID: 8402738
[TBL] [Abstract][Full Text] [Related]
45. Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids.
Pettersson OA; Olsson P; Lindström P; Sjöberg S; Carlsson J
Melanoma Res; 1993 Oct; 3(5):369-76. PubMed ID: 8292895
[TBL] [Abstract][Full Text] [Related]
46. Hyperthermic isolated limb perfusion with intra-arterial administration of carboplatin and/or interferon-beta for the treatment of malignant melanoma of the leg.
Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
J Dermatol; 1994 Nov; 21(11):915-22. PubMed ID: 7852655
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of B16 melanoma cells exposed in vitro to long-term IFN-alpha treatment (B16alpha cells) as a tumor vaccine in mice.
Wu TY; Fleischmann WR
J Interferon Cytokine Res; 1998 Oct; 18(10):829-39. PubMed ID: 9809618
[TBL] [Abstract][Full Text] [Related]
48. Anti-idiotype antibody vaccine therapies of cancer.
Bhattacharya-Chatterjee M; Foon KA
Cancer Treat Res; 1998; 94():51-68. PubMed ID: 9587682
[No Abstract] [Full Text] [Related]
49. Avoidable cancers in the Nordic countries. Radiation.
Winther JF; Ulbak K; Dreyer L; Pukkala E; Osterlind A
APMIS Suppl; 1997; 76():83-99. PubMed ID: 9462822
[TBL] [Abstract][Full Text] [Related]
50. The Ras farnesylation inhibitor BZA-5B increases the resistance to cisplatin in a human melanoma cell line.
Fokstuen T; Rabo YB; Zhou JN; Karlson J; Platz A; Shoshan MC; Hansson J; Linder S
Anticancer Res; 1997; 17(4A):2347-52. PubMed ID: 9252645
[TBL] [Abstract][Full Text] [Related]
51. Superficial spreading melanoma and blue naevus within naevus spilus--ultrastructural assessment of giant pigment granules.
Cox NH; Malcolm A; Long ED
Dermatology; 1997; 194(3):213-6. PubMed ID: 9187835
[TBL] [Abstract][Full Text] [Related]
52. Forequarter amputation with fasciocutaneous deltoid flap reconstruction for malignant tumors of the upper extremity.
Volpe CM; Peterson S; Doerr RJ; Karakousis CP
Ann Surg Oncol; 1997 Jun; 4(4):298-302. PubMed ID: 9181228
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells.
Carrel S; Schreyer M; Spagnoli G; Cerottini JC; Rimoldi D
Int J Cancer; 1996 Jul; 67(3):417-22. PubMed ID: 8707418
[TBL] [Abstract][Full Text] [Related]
54. Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor.
Ali MM; Huang DT; Goplerud DR; Howells R; Lu JD
Cancer; 1996 May; 77(9):1934-9. PubMed ID: 8646695
[TBL] [Abstract][Full Text] [Related]
55. Choroidal melanomas near the optic disk or macula. Long-term results after proton beam irradiation: a report of 3 cases.
Zehetmayer M; Menapace R
Ophthalmologica; 1993; 206(1):18-23. PubMed ID: 8278155
[TBL] [Abstract][Full Text] [Related]
56. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
[TBL] [Abstract][Full Text] [Related]
57. Risk of ocular melanoma in relation to cutaneous and iris naevi.
Bataille V; Sasieni P; Cuzick J; Hungerford JL; Swerdlow A; Bishop JA
Int J Cancer; 1995 Mar; 60(5):622-6. PubMed ID: 7860135
[TBL] [Abstract][Full Text] [Related]
58. Selective lethal effect of thymidine on human and mouse tumor cells.
Lee SS; Giovanella BC; Stehlin JS
J Cell Physiol; 1977 Sep; 92(3):401-5. PubMed ID: 903380
[TBL] [Abstract][Full Text] [Related]
59. Purification of soluble human melanoma-associated antigens.
Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
[TBL] [Abstract][Full Text] [Related]
60. Differential gene expression in tumor metastasis: Nm23.
Freije JM; MacDonald NJ; Steeg PS
Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():215-32. PubMed ID: 9053292
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
